Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX – Get Free Report) traded down 6.6% during trading on Friday . The stock traded as low as $15.37 and last traded at $15.37. 2,797 shares traded hands during mid-day trading, a decline of 83% from the average session volume of 16,252 shares. The stock had previously closed at $16.46.
Wall Street Analyst Weigh In
TLX has been the subject of several recent analyst reports. UBS Group assumed coverage on shares of Telix Pharmaceuticals Limited American Depositary Shares in a report on Friday, November 15th. They issued a “buy” rating and a $21.00 target price for the company. William Blair upgraded Telix Pharmaceuticals Limited American Depositary Shares to a “strong-buy” rating in a research report on Tuesday, November 19th.
Check Out Our Latest Research Report on TLX
Telix Pharmaceuticals Limited American Depositary Shares Stock Performance
About Telix Pharmaceuticals Limited American Depositary Shares
Telix Pharmaceuticals Limited is a biopharmaceutical company which focused on the development and commercialisation of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. It involved in developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases.
Featured Articles
- Five stocks we like better than Telix Pharmaceuticals Limited American Depositary Shares
- What Are Dividend Champions? How to Invest in the Champions
- S&P 500 ETFs: Expense Ratios That Can Boost Your Long-Term Gains
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- How AI Implementation Could Help MongoDB Roar Back in 2025
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Hedge Funds Boost Oil Positions: Is a Major Rally on the Horizon?
Receive News & Ratings for Telix Pharmaceuticals Limited American Depositary Shares Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Telix Pharmaceuticals Limited American Depositary Shares and related companies with MarketBeat.com's FREE daily email newsletter.
